Increased risk of stroke and transient ischemic attack in 5-year survivors of hodgkin lymphoma

Journal of the National Cancer Institute

Volumn 101, Issue 13, 2009, Pages 928-937

  De Bruin, Marie L ^a   Dorresteijn, Lucille D A ^b   Van't Veer, Mars B ^c   Krol, Augustinus D G ^d   Van Der Pal, Helena J ^e   Kappelle, Arnoud C ^b   Boogerd, Willem ^a   Aleman, Berthe M P ^a   Van Leeuwen, Flora E ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYTOSTATIC AGENT; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; CANCER SURVIVOR; CARDIOEMBOLISM; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COBALT THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; EMBOLISM; FEMALE; FOLLOW UP; HAZARD RATIO; HODGKIN DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; LARGE ARTERY ATHEROSCLEROSIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MULTICENTER STUDY; OBESITY; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; RADIATION; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SALVAGE THERAPY; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK; AGE; EARLY MENOPAUSE; MIDDLE AGED; NECK; NETHERLANDS; PROPORTIONAL HAZARDS MODEL; RADIATION EXPOSURE; RADIATION INJURY; RADIOTHERAPY; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; COHORT STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MALE; MEDIASTINUM; MENOPAUSE, PREMATURE; MIDDLE AGED; NECK; NETHERLANDS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RADIATION INJURIES; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE;

EID: 67649646579     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp147     Document Type: Article

References (34)

1. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21(18):3431-3439.
2. Aleman BM, van Leeuwen FE. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment? Hematol Oncol Clin North Am. 2007;21(5):961-975.
3. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late car- diotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109(5): 1878-1886.
4. Hancock SL, Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol. 1996; 6(3):225-242.
5. De Bruin ML, Huisbrink J, Hauptmann M, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood. 2008;111(1):101-108.
6. Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol. 2007; 25(12):1489-1497.
7. Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2005;23(27):6508-6515.
8. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290(21): 2831-2837.
9. Dorresteijn LD, Kappelle AC, Boogerd W, et al. Increased risk of isch- emic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20(1):282-288.
10. Gamble GE, Tyrrell P. Acute stroke following cisplatin therapy. Clin Oncol (R Coll Radiol). 1998;10(4):274-275.
11. Schiff D, Wen P. Cancer Neurology in Clinical Practice. Totawa, NJ: Humana Press; 2003.
12. Serrano-Castro PJ, Guardado-Santervas P, Olivares-Romero J. Ischemic stroke following cisplatin and 5-fluorouracil therapy: a transcranial Doppler study. Eur Neurol. 2000;44(1):63-64.
13. Ewer MS, Martin FJ, Henderson C, Shapiro CL, Benjamin RS, Gabizon AA. Cardiac safety of liposomal anthracyclines. Semin Oncol. 2004;31 (6 suppl 13):161-181.
14. Warlow CP, Dennis MS, van Gijn J, et al. Stroke: A Practical Guide to Management. 2nd ed. Malden, MA: Blackwell Science; 2001.
15. de Lecinana MA, Egido JA, Fernandez C, et al. Risk of ischemic stroke and lifetime estrogen exposure. Neurology. 2007;68(1):33-38.
16. Haynes JC, Machtay M, Weber RS, Weinstein GS, Chalian AA, Rosenthal DI. Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation. Laryngoscope. 2002; 112(10):1883-1887.
17. van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol. 1994;12(5):1063-1073.
18. van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18(3):487-497.
19. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. DeFINitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35-41.
20. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-607.
21. Raemaekers J, Kluin-Nelemans H, Teodorovic I, et al. The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38(suppl 4):S107-S113.
22. Gray L, Prosnitz LR. Dosimetry of Hodgkin's disease therapy using a 4 MV linear accelerator. Radiology. 1975;116(2):423-428.
23. van de Lisdonk EH, van den Bosch WJDH, Lagro-Janssen ALM, Schers HJ. Ziekten in de Huisartspraktijk. 5th ed. Maarssen, the Netherlands: Elsevier/Bunge; 2008.
24. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706.
25. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume II- The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer Press; 1987.
26. Smith GL, Smith BD, Buchholz TA, et al. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 2008;26(30):5119-5125.
27. Witteman JC, D'Agostino RB, Stijnen T, et al. G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham Heart Study. Am J Epidemiol. 1998; 148(4):5119-5125.
28. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612-1623.
29. Varona JF, Bermejo F, Guerra JM, Molina JA. Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol. 2004; 251(12):1507-1514.
30. Hobson RW, Mackey WC, Ascher E, et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg. 2008;48(2):480-486.
31. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990;53(1):16-22.
32. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003; 74(3):317-321.
33. Li C, Hedblad B, Rosvall M, Buchwald F, Khan FA, Engstrom G. Stroke incidence, recurrence, and case-fatality in relation to socioeconomic position: a population-based study of middle-aged Swedish men and women. Stroke. 2008;39(8):2191-2196.
34. Wolfe CD, Giroud M, Kolominsky-Rabas P, et al. Variations in stroke incidence and survival in 3 areas of Europe. European Registries of Stroke (EROS) Collaboration. Stroke. 2000;31(9):2074-2079.